Selected Publications
Huang, J., Sati, S., Murphy, C., Spencer, C.A., Rapp Reyes, E., Prouty, S., Korte, S., Ahart, O., Sheng, E., Jones, P., Kersh, A.E., Leung, D., Leung, T.H.: Granulocyte-colony stimulating factor promotes scarless tissue regeneration
Cell Reports
43 (10): 11472,2024.
Sati, S., Jones, P.*, Kersh, A.E., * Murphy, C.*, Hedberg, M.L., Huang, J., Jain, V., Gregory, S.G., Leung, D.H., Rosenbach, M., Leung, T.H.: CXCR4-expressing group 1 innate lymphoid cells in the pathogenesis and diagnosis of sarcoidosis
J Clin Invest 134 (17): e178711,2024.
Kersh, A.E., Sati, S., Murphy, C., Ahart, O., Leung, T.H.: CCL19 amplifies T-lymphocyte recruitment and retention in lichen planus
JCI Insight 9 (20): e179899,2024.
Abbott JJ, Jiang AJ, Rauck C, Frank DM, Fortuna D, Kersh A, Rubin AI.: Cutaneous metastatic gastric carcinoma with plasmacytoid features: A novel histopathologic pitfall in the diagnosis of primary cutaneous plasmacytoma J Cutan Pathol 50 (1): 8-11,2023.
Bhattacharya S, Basu S, Sheng E, Murphy C, Wei J, Kersh AE, Nelson CA, Bryer JS, Ashchyan HA, Steele K, Forrestel A, Seykora JT, Micheletti RG, James WD, Rosenbach M, Leung TH.: Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome J Clin Invest 133 : e162137,2023.
Bhattarcharya, S., Sheng, E., Murphy, C., Wei, J., Kersh, A.E., Nelson, C.A., Aschanyan, H.A., Steele, K., Forrestel, A., Seykora, J.T., Micheletti, R.G., James, W.D., Rosenbach, M., Leung, T.H.: Targeted therapy guided by molecular identification of PIK3R1 mutation in acute febrile neutrophilic dermatosis J Clin Invest 133 (1): e162137,2023.
Torre EA, Kersh AE, Fischer AS, Xu X, Rosenbach M, Shields BE.: Angiokeratoma-like purpuric palmar nodules following chemotherapy Dermatol Online J 27 (8): 2021.
Kersh AE, Johansen M, Ojeaga A, de la Feld S.: Hand Dermatitis in the Time of COVID-19: A Review of Occupational Irritant Contact Dermatitis Dermatitis 32 (2): 86-93,2021.
Kersh AE, Schuchter LM, Elenitsas R, Chu EY.: Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy Immunotherapy 12 (13): 951-956,2020.
Bhattarcharya, S., Sheng, E., Murphy, C., Wei, J., Kersh, A.E., Nelson, C.A., Aschanyan, H.A., Steele, K., Forrestel, A., Seykora, J.T., Micheletti, R.G., James, W.D., Rosenbach, M., Leung, T.H.: Targeted therapy guided by molecular identification of PIK3R1 mutation in acute febrile neutrophilic dermatosis J Clin Invest 133 (1): 202.
Academic Contact Information
421 Curie Boulevard
Biomedical Research Building II/III, #1040
Philadelphia,
PA
19104
Patient appointments: 800-789-7366